• DOXEPIN CHEMBL1628227 FDA Approved

    Alternate Names:

    Sinequan
    Doxepin
    Sinepin
    P-3693A
    Zonalon
    4710
    C06971
    CN(C)CCC=C1C2CCCCC2COC3C1CCCC3
    PA449409
    0378-1049-01
    1225
    158785
    DAP000177
    TRIADAPIN
    ADAPIN
    DB01142
    667477
    DOXEPINA [INN-SPANISH]
    APONAL
    QUITAXON
    DOXEPINE
    CURATIN
    DOXEPINUM [INN-LATIN]
    DOXEPIN HCL
    1913425
    LOPAC0_000339
    C19H21NO
    CIDOXEPINUM
    1-PROPANAMINE, 3-DIBENZ(B,E)OXEPIN-11(6H)-YLIDENE-N,N-DIMETHYL-
    AC1LDI5F
    DOXEPIN [USAN]
    DIVK1C_000431
    DIBENZ(B,E)OXEPIN-DELTA(SUP 11(6H)),GAMMA-PROPYLAMINE, N,N-DIMETHYL-
    CHEBI:36691
    TOCRIS-0508
    SPBIO_000206
    (Z)-DOXEPIN
    BPBIO1_000118
    CIDOXEPINA
    DIBENZ(B,E)OXEPIN-.DELTA.11(6H),.GAMMA.-PROPYLAMINE, N,N-DIMETHYL-
    CID667468
    MOLI001594
    3607-18-9
    KBIO3_001154
    SPBIO_002325
    CID667477
    (3Z)-3-(6H-BENZO[C][1]BENZOXEPIN-11-YLIDENE)-N,N-DI(METHYL)PROPAN-1-AMINE
    BRD-K36616567-003-01-5
    UNII-5ASJ6HUZ7D
    KBIO2_001285
    (3Z)-3-(6H-BENZO[C][1]BENZOXEPIN-11-YLIDENE)-N,N-DIMETHYLPROPAN-1-AMINE
    MF 10
    KBIO2_006421
    11-(3-DIMETHYLAMINOPROPYLIDENE)-6,11-DIHYDRODIBENZ(B,E)OXIPIN
    L000699
    BRD-K37694030-003-02-8
    AKOS001582771
    AC1L1FAW
    CAS-1229-29-4
    CID3158
    SPECTRUM_000805
    D07875
    NCGC00015344-02
    AC1NUW4A
    3-DIBENZ[B,E]OXEPIN-11(6H)-YLIDENE-N,N-DIMETHYL-1-PROPANAMINE
    1668-19-5
    IDI1_000431
    DOXEPIN (Z)-ISOMER
    PRESTWICK3_000263
    NCGC00024623-02
    DOXEPINA
    LS-61638
    SPECTRUM4_000526
    LS-174582
    PRESTWICK1_000263
    CID10039438
    CIS-DOXEPIN
    CHEMBL101740
    BSPBIO_001934
    NCGC00015344-01
    AC1LDI63
    PRESTWICK2_000263
    11-(3-(DIMETHYLAMINO)PROPYLIDENE)-6H-DIBENZ(B,E)OXEPINE
    OPREA1_473232
    NCGC00024623-01
    (3E)-3-DIBENZO[B,E]OXEPIN-11(6H)-YLIDENE-N,N-DIMETHYLPROPAN-1-AMINE
    KBIO1_000431
    DOXEPIN (INN)
    CID5462131
    CIS-N-(3-(6H-DIBENZ(B,E)OXEPIN-11-YLIDEN)PROPYL)-N,N-DIMETHYLAMIN
    N,N-DIMETHYLDIBENZ(B,E)OXEPIN-DELTA(11(6H),GAMMA)-PROPYLAMINE
    KBIOGR_001131
    (3Z)-3-DIBENZO[B,E]OXEPIN-11(6H)-YLIDENE-N,N-DIMETHYLPROPAN-1-AMINE
    DOXEPIN, HYDROCHLORIDE
    SPECTRUM5_001051
    PRESTWICK0_000263
    3-DIBENZO[B,E]OXEPIN-11(6H)-YLIDENE-N,N-DIMETHYLPROPAN-1-AMINE
    CIDOXEPIN [INN]
    NCGC00015344-04
    11-(3-DIMETHYLAMINO-PROPYLIDEN)-6,11-DIHYDRO-DIBENZ(B,E)OXIPIN
    DIBENZ(B,E)OXEPIN-.DELTA.(SUP 11(6H)),.GAMMA.-PROPYLAMINE, N,N-DIMETHYL-
    NCGC00162127-01
    NINDS_000431
    CHEBI:4710
    DOXEPINUM
    CHEBI:36692
    1-PROPANAMINE, 3-DIBENZ[B,E]OXEPIN-11(6H)-YLIDENE-N,N-DIMETHYL-
    CIDOXEPIN
    HSDB 3069
    LOPAC-D-4526
    MOLPORT-003-847-024
    KBIO2_003853
    BSPBIO_000106
    MOLPORT-005-933-834
    BRD-K54462405-003-03-3
    3-(6H-BENZO[C][1]BENZOXEPIN-11-YLIDENE)-N,N-DIMETHYLPROPAN-1-AMINE
    SPECTRUM3_000407
    SINEQUAN (TN)
    CCRIS 9176
    DOXEPIN HYDROCHLORIDE,
    SPECTRUM2_000133
    (3E)-3-(6H-BENZO[C][1]BENZOXEPIN-11-YLIDENE)-N,N-DIMETHYLPROPAN-1-AMINE
    UNII-F96TTB8728
    KBIOSS_001285
    D7V
    (3E)-3-DIBENZO[B,E]OXEPIN-11(6H)-YLIDENE-N,N-DIMETHYLPROPAN-1-AMINE(3Z)-3-DIBENZO[B,E]OXEPIN-11(6H)-YLIDENE-N,N-DIMETHYLPROPAN-1-AMINE
    (3Z)-3-(DIBENZO[B,E]OXEPIN-11(6H)-YLIDENE)-N,N-DIMETHYLPROPAN-1-AMINE
    N,N-DIMETHYLDIBENZ(B,E)OXEPIN-.DELTA.11(6H),.GAMMA.-PROPYLAMINE
    3-DIBENZO[B,E]OXEPIN-11(6H)-YLIDENE-N,N-DIMETHYL-1-PROPANAMINE #
    UNII-5ASJ6HUZ7D COMPONENT ODQWQRRAPPTVAG-BOPFTXTBSA-N
    I14-15315
    NSC 108160
    BDBM50079527
    ODQWQRRAPPTVAG-BOPFTXTBSA-N
    DOXEPIN HYDROCHLORIDE (SALT/MIX)
    ZINC1148
    SCHEMBL684837
    P-3693A (SALT/MIX)
    NOVOXAPIN (SALT/MIX)
    SINEQUAN (SALT/MIX)
    QUITAXON (SALT/MIX)
    ZONALON (SALT/MIX)
    CURATIN (SALT/MIX)
    APONAL (SALT/MIX)
    PRUDOXIN
    F96TTB8728
    667468
    3-(6H-BENZO[C][1]BENZOXEPIN-11-YLIDENE)-N,N-DIMETHYL-PROPAN-1-AMINE
    11-(3-DIMETHYLAMINO-PROPYLIDENE)- 6,11-DIHYDRODIBENZO- [B,E]-OXEPINE
    11-(3-DIMETHYLAMINO-PROPYLIDENE)-6,11-DIHYDRODIBENZO-[B,E]-OXEPINE
    KB-233534
    AN-20679
    NCGC00015344-05
    ODQWQRRAPPTVAG-UHFFFAOYSA-N
    SCHEMBL28054
    DIMETHYL(3-{9-OXATRICYCLO[9.4.0.03,8]PENTADECA-1(11),3(8),4,6,12,14-HEXAEN-2-YLIDENE}PROPYL)AMINE
    DIMETHYL({3-[(2E)-9-OXATRICYCLO[9.4.0.0^{3,8}]PENTADECA-1(11),3(8),4,6,12,14-HEXAEN-2-YLIDENE]PROPYL})AMINE
    DIMETHYL({3-[(2E)-9-OXATRICYCLO[9.4.0.0?,?]PENTADECA-1(15),3,5,7,11,13-HEXAEN-2-YLIDENE]PROPYL})AMINE
    DIMETHYL({3-[(2E)-9-OXATRICYCLO[9.4.0.0(3),?]PENTADECA-1(15),3,5,7,11,13-HEXAEN-2-YLIDENE]PROPYL})AMINE
    5EH
    (E)-3-(DIBENZO[B,E]OXEPIN-11(6H)-YLIDENE)-N,N-DIMETHYLPROPAN-1-AMINE
    (3E)-3-(DIBENZO[B,E]OXEPIN-11(6H)-YLIDENE)-N,N-DIMETHYLPROPAN-1-AMINE
    UNII-5ASJ6HUZ7D COMPONENT ODQWQRRAPPTVAG-GZTJUZNOSA-N
    3B2-6499
    FT-0601521
    US8629135, SW-07
    PL047943
    DR000955
    BC225584
    AK-70938
    AK-60057
    AJ-08007
    CCG-204434
    AKOS016014904
    BDBM112780
    ZINC1331
    GTPL3958
    GTPL1225
    851NLB57HQ
    SCHEMBL116895
    CHEMBL860
    DOXEPIN [INN:BAN]
    E-DOXEPIN
    DOXEPIN, (E)-
    [11C]-DOXEPIN
    [11C]DOXEPIN
    SINEQUAN, ZONALON
    (E)-DOXEPIN
    TRANS-DOXEPIN
    SINEQUANREG
    DEPTRANREG
    NCGC00015344-03
    3607-34-9
    UNII-851NLB57HQ
    3-(DIBENZO[B,E]OXEPIN-11(6H)-YLIDENE)-N,N-DIMETHYLPROPAN-1-AMINE
    3158
    5462131
    135650208

    Drug Info:

    Drug Indications hypnotic
    FDA Approval approved
    Drug Class Small Molecule
    Drug Indications antimigraine agent
    ATC n06aa(non-selective monoamine reuptake inhibitors)
    Drug Type drug/small molecule
    Drug Class antidepressive agents, tricyclic
    Year of Approval 1969
    Drug Class antipruritics
    (4 More Sources)

    Publications:

  • Interaction Types:
    antagonist
    inhibitor

    Interaction Info:
    Specific Action of the Ligand Antagonist
    Endogenous Drug? False
    Trial Name Silenor (SO-101)

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Trial Name doxepin nasal solution,Dolorac
    Novel drug target Established target
    Trial Name Silenor (SO-101)

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False
    Direct Interaction? True

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Trial Name Silenor (SO-101)
    Novel drug target Established target

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Trial Name Silenor (SO-101)
    Novel drug target Established target

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Trial Name Silenor (SO-101)
    Novel drug target Established target

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Trial Name Silenor (SO-101)
    Novel drug target Established target

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Trial Name Silenor (SO-101)
    Novel drug target Established target

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Trial Name Silenor (SO-101)
    Novel drug target Established target

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Trial Name Silenor (SO-101)
    Novel drug target Established target

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Trial Name Silenor (SO-101)
    Novel drug target Established target

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Trial Name Silenor (SO-101)
    Novel drug target Established target

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:

    Publications:

    • Version: 12-July-2012

    Alternate Names:
    1913425 dpd
    DOXEPIN HCL Drug Generic Name
    DOXEPINUM [INN-LATIN] Drug Generic Name

    Drug Info:
    Drug Type drug/small molecule
    ATC n06aa(non-selective monoamine reuptake inhibitors)

    Publications:

    • Version: 01-August-2011

    Alternate Names:
    DOXEPIN Primary Drug Name

    Drug Info:
    Drug Class antipruritics
    Year of Approval 1969
    Drug Class antidepressive agents, tricyclic

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antimigraine agent
    Drug Class Small Molecule
    FDA Approval approved

    Publications:

    • Version: 27-September-2017

    Alternate Names:
    DOXEPIN GuideToPharmacology Ligand Name
    135650208 PubChem Drug SID

    Drug Info:

    Publications:

    • Version: 4.3.02 (25-August-2011)

    Alternate Names:
    KBIOSS_001285 Drug Synonym
    UNII-F96TTB8728 Drug Synonym
    (3E)-3-(6H-BENZO[C][1]BENZOXEPIN-11-YLIDENE)-N,N-DIMETHYLPROPAN-1-AMINE Drug Synonym

    Drug Info:

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    SPECTRUM_000805 Drug Synonym
    DOXEPIN pubchem_primary_name
    3158 PubChem CID

    Drug Info:

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    AC1NUW4A pubchem_primary_name
    5462131 PubChem CID
    MOLI001594 Drug Synonym

    Drug Info:

    Publications:

    • Version: 15-September-2017

    Alternate Names:

    Drug Info:

    Publications: